Astera Labs, Inc. (NASDAQ:ALAB) Given Consensus Recommendation of “Moderate Buy” by Brokerages

Astera Labs, Inc. (NASDAQ:ALABGet Free Report) has received an average recommendation of “Moderate Buy” from the eleven brokerages that are covering the company, Marketbeat reports. One analyst has rated the stock with a hold rating and ten have issued a buy rating on the company. The average twelve-month price target among brokers that have issued a report on the stock in the last year is $71.36.

Several analysts have recently weighed in on the stock. JPMorgan Chase & Co. lowered their target price on shares of Astera Labs from $95.00 to $70.00 and set an “overweight” rating on the stock in a report on Wednesday, August 7th. Morgan Stanley dropped their target price on Astera Labs from $85.00 to $55.00 and set an “equal weight” rating on the stock in a research report on Wednesday, August 7th. Needham & Company LLC reduced their price target on Astera Labs from $85.00 to $65.00 and set a “buy” rating for the company in a report on Wednesday, August 7th. Stifel Nicolaus decreased their price target on Astera Labs from $87.00 to $80.00 and set a “buy” rating on the stock in a research note on Monday, August 5th. Finally, Roth Mkm cut their price objective on Astera Labs from $85.00 to $60.00 and set a “buy” rating for the company in a research report on Wednesday, August 7th.

View Our Latest Report on ALAB

Institutional Trading of Astera Labs

Several institutional investors and hedge funds have recently modified their holdings of the business. Sei Investments Co. acquired a new position in Astera Labs in the 1st quarter valued at about $952,000. Vanguard Group Inc. purchased a new position in shares of Astera Labs during the first quarter valued at approximately $127,268,000. Forge First Asset Management Inc. acquired a new stake in Astera Labs during the first quarter worth approximately $1,143,000. Price T Rowe Associates Inc. MD purchased a new stake in Astera Labs in the 1st quarter worth approximately $44,514,000. Finally, Allspring Global Investments Holdings LLC acquired a new position in Astera Labs in the 1st quarter valued at $18,666,000.

Astera Labs Trading Down 2.2 %

ALAB opened at $39.79 on Friday. Astera Labs has a 52 week low of $36.22 and a 52 week high of $95.21. The stock’s 50 day moving average price is $51.21.

Astera Labs (NASDAQ:ALABGet Free Report) last announced its earnings results on Tuesday, August 6th. The company reported $0.13 EPS for the quarter, beating analysts’ consensus estimates of $0.11 by $0.02. The business had revenue of $76.90 million during the quarter, compared to analyst estimates of $72.41 million. The firm’s revenue for the quarter was up 17.8% on a year-over-year basis. Equities analysts predict that Astera Labs will post -0.56 earnings per share for the current fiscal year.

Astera Labs Company Profile

(Get Free Report

Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.

Featured Articles

Analyst Recommendations for Astera Labs (NASDAQ:ALAB)

Receive News & Ratings for Astera Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astera Labs and related companies with MarketBeat.com's FREE daily email newsletter.